Schrödinger investor relations material

Schrödinger, Inc. provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The Company's solutions enable life science researchers to identify likeliest candidates from compound libraries and screen them against biological targets in the systems biology environment. Schrödinger Inc. was founded in 1990 and is based in New York.